Department of Anatomy, School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, P. R. China.
State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P. R. China.
Am J Chin Med. 2021;49(3):627-643. doi: 10.1142/S0192415X21500282. Epub 2021 Mar 3.
Depression is a common neuropsychiatric symptom of Parkinson's disease (PD), resulting in a lower quality of life and cognitive impairment in PD patients. Traditional Chinese medicine (TCM) formulas have been widely used in neurodegenerative disease and neuropsychic disorders to improve life quality of patients in ethnomedicine. TCM formulas combined with selective serotonin reuptake inhibitors (SSRIs) also have a positive effect on depressed PD compared with SSRIs as reported by several clinical studies. However, the results are discordant and failed to be conclusive. We aim to evaluate the efficacy of TCM formulas combined with SSRIs for depressed PD in this systematic review. We searched literatures from PubMed, Web of Science, Medline, Embase, Google Scholar, Chinese National Knowledge Infrastructure, Wanfang Database, and VIP Information Database before July 2020. We included randomized controlled trials investigating the efficacy of TCM formulas combined with SSRIs on depressed PD patients. This analysis was according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Eleven randomized clinical trials involving 861 subjects were enrolled in this analysis. The overall results showed that TCM formulas combined with SSRIs significantly improved the depression score [weighted mean difference (WMD): -4.920, 95% confidence interval (CI): (-5.999, -3.840); [Formula: see text]¡ 0.001] and had a statistical significance on Unified Parkinson's Disease Rating Scale II score [WMD: -1.209, 95% CI: (-1.561, -0.857); [Formula: see text] < 0.001]. Furthermore, we observed that Chai-Hu-Shu-Gan Powder combined with SSRIs had a significant improvement on the depressive symptom in PD compared to the SSRIs alone [WMD: -5.390, 95% CI: (-7.66, -3.11); [Formula: see text] < 0.001]. No severe side events were reported in these included trials. This systematic review provided the evidences that TCM formulas combined with SSRIs might be helpful and safe in the treatment of depression of PD, including Chai-Hu-Shu-Gan Powder. Also, more randomized double-blinded trials with reliable design are required in the future.
抑郁症是帕金森病(PD)常见的神经精神症状,导致 PD 患者的生活质量下降和认知功能受损。在民族医学中,中药方剂已广泛用于治疗神经退行性疾病和神经精神障碍,以改善患者的生活质量。几项临床研究报告称,与 SSRIs 相比,中药方剂联合选择性 5-羟色胺再摄取抑制剂(SSRIs)对抑郁性 PD 也有积极作用。然而,结果并不一致,也未能得出结论。我们旨在通过系统评价评估中药方剂联合 SSRIs 治疗抑郁性 PD 的疗效。我们从 PubMed、Web of Science、Medline、Embase、Google Scholar、中国国家知识基础设施、万方数据库和 VIP 信息数据库检索文献,检索时间截至 2020 年 7 月。我们纳入了研究中药方剂联合 SSRIs 治疗抑郁性 PD 患者疗效的随机对照试验。这项分析是根据系统评价和荟萃分析的首选报告项目进行的。共有 11 项随机临床试验纳入 861 名受试者。总体结果表明,中药方剂联合 SSRIs 可显著改善抑郁评分[加权均数差(WMD):-4.920,95%置信区间(CI):(-5.999,-3.840);[Formula: see text]¡0.001],且对统一帕金森病评定量表 II 评分有统计学意义[WMD:-1.209,95%CI:(-1.561,-0.857);[Formula: see text]<0.001]。此外,我们观察到与 SSRIs 单药治疗相比,柴胡疏肝散联合 SSRIs 可显著改善 PD 患者的抑郁症状[WMD:-5.390,95%CI:(-7.66,-3.11);[Formula: see text]<0.001]。这些纳入的试验中未报告严重的不良反应事件。这项系统评价提供了证据,表明中药方剂联合 SSRIs 可能有助于治疗 PD 患者的抑郁症,包括柴胡疏肝散,且安全有效。未来还需要更多设计可靠的随机双盲试验。